Data as of Aug 29
| -0.65 / -1.21%|
The 3 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 59.00, with a high estimate of 62.00 and a low estimate of 57.00. The median estimate represents a +11.07% increase from the last price of 53.12.
The current consensus among 3 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.